What is Styku?
Styku operates at the intersection of biometric data and physical wellness, providing advanced 3D body scanning technology that serves as a cornerstone for health clubs, medical aesthetics clinics, and physical therapy practices. By delivering non-invasive, high-precision body composition analysis, the company enables professionals to track physiological changes with unprecedented accuracy. This data-driven approach not only enhances client engagement but also provides actionable insights that drive business outcomes in the competitive fitness and weight loss markets. Through its sophisticated modeling software, Styku has established itself as a critical partner for organizations seeking to integrate objective health metrics into their service offerings.
How much funding has Styku raised?
Styku has raised a total of $347K across 2 funding rounds:
Debt
$150K
Debt
$197K
Debt (2020): $150K with participation from PPP
Debt (2021): $197K led by PPP
Key Investors in Styku
PPP
Public-Private Partnership
Undisclosed Investors
Undisclosed Investors
What's next for Styku?
With the recent capital injection, Styku is well-positioned to accelerate its expansion into broader medical and wellness ecosystems. The company's focus on late-stage scaling suggests a strategic pivot toward deepening its software-as-a-service capabilities and expanding its footprint in clinical settings. By refining its analytics engine and increasing the accessibility of its scanning hardware, Styku aims to solidify its leadership in the body composition market. Future growth will likely be defined by the integration of predictive health modeling and the expansion of its enterprise-grade diagnostic tools, ensuring that the firm remains at the forefront of the digital health revolution.
See full Styku company page
